glp-1 weight patch How to Wear Patches: Current Status and Approved Alternatives GLP-1 Patches for Weight Loss:

Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets

Oral Wegovy is FDA-approved for weight loss in adults with obesity or overweight and at least one weight-related condition

Short-chain fatty acids stimulate the release of gut hormones via the G-protein-coupled receptor FFAR2

For patients with more troublesome side effects, additional strategies are often necessary to manage symptoms and permit drug continuation

doi: 10.3389/fphar.2024.1397029, 60

GLP-1 treatments may be particularly beneficial for those patients who are overweight or obese and have associated conditions such as type 2 diabetes or significant cardiovascular risk factors